Cargando…

Autoimmune pulmonary alveolar proteinosis in an adolescent successfully treated with inhaled rhGM-CSF (molgramostim)

Autoimmune pulmonary alveolar proteinosis (aPAP) is a rare parenchymal lung disease characterized by accumulation of surfactant in the airways with high levels of granulocyte-macrophage colony stimulating factor (GM-CSF) antibodies in blood. Disease leads to hypoxemic respiratory failure. Whole lung...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gajewska, Marta E., Sritharan, Sajitha S., Santoni-Rugiu, Eric, Bendstrup, Elisabeth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5925949/ https://www.ncbi.nlm.nih.gov/pubmed/29719809 http://dx.doi.org/10.1016/j.rmcr.2018.02.005

Ejemplares similares

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
por: Rampling, R., et al.
Publicado: (1994)

Topically administered rhGM-CSF affects PPARβ expression in the stasis zone
por: Fu, Gen-Feng, et al.
Publicado: (2017)

Tumor growth under rhGM-CSF application in an orthotopic rodent glioma model
por: Linsenmann, Thomas, et al.
Publicado: (2019)

Neutralization and clearance of GM-CSF by autoantibodies in pulmonary alveolar proteinosis
por: Piccoli, Luca, et al.
Publicado: (2015)

Clinical study of rhGM-CSF for the treatment of pulmonary exogenous acute respiratory distress syndrome by modulating alveolar macrophage subtypes: A randomized controlled trial
por: Sun, Jie, et al.
Publicado: (2023)

The Role of GM-CSF Autoantibodies in Infection and Autoimmune Pulmonary Alveolar Proteinosis: A Concise Review
por: Ataya, Ali, et al.
Publicado: (2021)

Bioavailability of Orally Administered rhGM-CSF: A Single-Dose, Randomized, Open-Label, Two-Period Crossover Trial
por: Zhang, Wenping, et al.
Publicado: (2009)

GM-CSF Autoantibody-positive Pulmonary Alveolar Proteinosis with Simultaneous Myeloproliferative Neoplasm
por: Imoto, Naoto, et al.
Publicado: (2017)

Proteinosis alveolar. Remisión completa tras tratamiento con GM-CSF inhalado
por: López Monzoni, Sonia, et al.
Publicado: (2022)

Characterization of a novel + 70 Da modification in rhGM-CSF expressed in E. coli using chemical assays in combination with mass spectrometry
por: Sandberg, Magdalena Widgren, et al.
Publicado: (2021)

Pulmonary Alveolar Proteinosis Refractory to Plasmapheresis and Rituximab despite GM-CSF Antibody Reduction
por: Keske, Aysenur, et al.
Publicado: (2022)

Neutralizing GM-CSF autoantibodies in pulmonary alveolar proteinosis, cryptococcal meningitis and severe nocardiosis
por: Salvator, Hélène, et al.
Publicado: (2022)

Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions--a phase I dose-toxicity study.
por: Steward, W. P., et al.
Publicado: (1989)

Utility of anti-GM-CSF antibodies in the diagnosis of pulmonary alveolar proteinosis: a case report
por: Sierra-Rivera, Antonio, et al.
Publicado: (2023)

Nebulised granulocyte–macrophage colony-stimulating factor (GM-CSF) in autoimmune pulmonary alveolar proteinosis: a systematic review and meta-analysis
por: Munsif, Maitri, et al.
Publicado: (2023)

Pulmonary alveolar proteinosis - a crazy presentation of dyspnea
por: Skov, Inge Raadal, et al.
Publicado: (2018)

Efficacy of Low-Dose rhGM-CSF Treatment in a Patient With Severe Congenital Neutropenia Due to CSF3R Deficiency: Case Report of a Novel Biallelic CSF3R Mutation and Literature Review
por: Zhou, Junli, et al.
Publicado: (2021)

Immunization With the CSF-470 Vaccine Plus BCG and rhGM-CSF Induced in a Cutaneous Melanoma Patient a TCRβ Repertoire Found at Vaccination Site and Tumor Infiltrating Lymphocytes That Persisted in Blood
por: Aris, Mariana, et al.
Publicado: (2019)

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment
por: Bosteels, Cedric, et al.
Publicado: (2022)

Alveolar proteinosis due to toxic inhalation at workplace
por: Santos, Gabriela F., et al.
Publicado: (2020)

Autoimmune pulmonary alveolar proteinosis in children
por: Griese, Matthias, et al.
Publicado: (2022)

Familial idiopathic pulmonary fibrosis in a young female
por: Sritharan, Sajitha S., et al.
Publicado: (2018)

Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
por: Suzuki, Takuji, et al.
Publicado: (2008)

Autoimmune pulmonary alveolar proteinosis in a patient with sarcoidosis
por: Tanaka, Yuko, et al.
Publicado: (2019)

Autoimmune pulmonary alveolar proteinosis prior to myelodysplastic syndrome
por: Foo, Chuan Tai, et al.
Publicado: (2020)

Genetic determinants of risk in autoimmune pulmonary alveolar proteinosis
por: Sakaue, Saori, et al.
Publicado: (2021)

Rituximab rescue therapy for autoimmune pulmonary alveolar proteinosis
por: Bird, Daniel, et al.
Publicado: (2022)

Upper Lobe-predominant Autoimmune Pulmonary Alveolar Proteinosis
por: Goda, Mayu, et al.
Publicado: (2022)

Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis
por: Hildebrandt, Jenna, et al.
Publicado: (2014)

Pulmonary alveolar proteinosis: An autoimmune disease lacking an HLA association
por: Anderson, Kirsten, et al.
Publicado: (2019)

Autoimmune pulmonary alveolar proteinosis mimicking Mycoplasma pneumonia in an adolescent
por: Meka, Shaiva Ginoya, et al.
Publicado: (2020)

B cell‐activating factors in autoimmune pulmonary alveolar proteinosis
por: Hirose, Masaki, et al.
Publicado: (2021)

Aspergillus Nodule in a Patient With Autoimmune Pulmonary Alveolar Proteinosis
por: Nagaoka, Yuhei, et al.
Publicado: (2022)

Peripheral alveolar nitric oxide concentration reflects alveolar inflammation in autoimmune pulmonary alveolar proteinosis
por: Hirano, Taizou, et al.
Publicado: (2018)

Atypical alveolar proteinosis
por: Rajaonarison Ny Ony Narindra, Lova Hasina, et al.
Publicado: (2018)

Pulmonary Alveolar Proteinosis in Setting of Inhaled Toxin Exposure and Chronic Substance Abuse
por: Li, Meirui, et al.
Publicado: (2018)

Pivotal Roles of GM-CSF in Autoimmunity and Inflammation
por: Shiomi, Aoi, et al.
Publicado: (2015)

Successful Treatment of Autoimmune Pulmonary Alveolar Proteinosis in a Pediatric Patient
por: Turkalj, Mirjana, et al.
Publicado: (2016)

Incidence of autoimmune pulmonary alveolar proteinosis estimated using Poisson distribution
por: Kitamura, Nobutaka, et al.
Publicado: (2019)

Autoimmune pulmonary alveolar proteinosis presenting peripheral ground‐glass opacities
por: Sugino, Keishi, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_7ajqpl34g6fbq42kuqvti923rg